Published in Osteoporos Int on September 17, 2008
Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporos Int (2009) 1.43
Comparison of 5766 vertebral compression fractures treated with or without kyphoplasty. Clin Orthop Relat Res (2010) 1.17
Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures. Osteoporos Int (2011) 1.11
Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures. Osteoporos Int (2010) 0.94
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures. Osteoporos Int (2013) 0.91
The proper volume and distribution of cement augmentation on percutaneous vertebroplasty. J Korean Neurosurg Soc (2010) 0.90
Risk factors of new symptomatic vertebral compression fractures in osteoporotic patients undergone percutaneous vertebroplasty. Eur Spine J (2015) 0.87
Analysis of risk factors of subsequent fractures after vertebroplasty. Eur Spine J (2013) 0.87
Vertebroplasty and the placebo response. Radiology (2011) 0.86
Bone healing using a bi-phasic ceramic bone substitute demonstrated in human vertebroplasty and with histology in a rabbit cancellous bone defect model. Interv Neuroradiol (2012) 0.85
Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture. Osteoporos Int (2013) 0.84
Current perspectives on percutaneous vertebroplasty: current evidence/controversies, patient selection and assessment, and technique and complications. Radiol Res Pract (2011) 0.81
Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int (2011) 0.80
New vertebral fractures after vertebroplasty: 2-year results from a randomised controlled trial. Arch Osteoporos (2015) 0.80
The importance of mechanics in the pathogenesis of fragility fractures of the femur and vertebrae. Clin Cases Miner Bone Metab (2010) 0.79
The early stage adjacent disc degeneration after percutaneous vertebroplasty and kyphoplasty in the treatment of osteoporotic VCFs. PLoS One (2012) 0.78
Biomechanical comparison of vertebral augmentation with silicone and PMMA cement and two filling grades. Eur Spine J (2013) 0.77
Domino Effect: mechanic factors role. Clin Cases Miner Bone Metab (2011) 0.77
At least one cyclic teriparatide administration can be helpful to delay initial onset of a new osteoporotic vertebral compression fracture. Yonsei Med J (2014) 0.77
Acupuncture in patients with a vertebral compression fracture: a protocol for a randomized, controlled, pilot clinical trial. J Pharmacopuncture (2015) 0.75
Bone Cement Dislodgement: One of Complications Following Bone Cement Augmentation Procedures for Osteoporotic Spinal Fracture. J Korean Neurosurg Soc (2015) 0.75
Percutaneous vertebroplasty of the entire thoracic and lumbar vertebrae for vertebral compression fractures related to chronic glucocorticosteriod use: case report and review of literature. Korean J Radiol (2014) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine (Phila Pa 1976) (2001) 4.79
Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology (2003) 3.30
Vertebroplasty: cement leakage into the disc increases the risk of new fracture of adjacent vertebral body. AJNR Am J Neuroradiol (2004) 2.91
Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford) (2000) 2.76
Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med (2003) 2.66
Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust (2006) 2.40
Incidence of subsequent vertebral fracture after kyphoplasty. Spine (Phila Pa 1976) (2004) 2.35
Adjacent vertebral failure after vertebroplasty. A biomechanical investigation. J Bone Joint Surg Br (2002) 2.28
New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol (2006) 2.05
The effect of cement augmentation on the load transfer in an osteoporotic functional spinal unit: finite-element analysis. Spine (Phila Pa 1976) (2003) 2.01
Leakage of cement in percutaneous transpedicular vertebroplasty for painful osteoporotic compression fractures. J Bone Joint Surg Br (2003) 1.91
Vertebroplasty, first 1000 levels of a single center: evaluation of the outcomes and complications. AJNR Am J Neuroradiol (2007) 1.71
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
Load shift of the intervertebral disc after a vertebroplasty: a finite-element study. Eur Spine J (2003) 1.50
Percutaneous vertebral augmentation. Spine J (2004) 1.48
Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc (2004) 1.44
Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty. Spine (Phila Pa 1976) (2004) 1.43
Percutaneous vertebroplasty for osteoporotic compression fracture: multivariate study of predictors of new vertebral body fracture. Cardiovasc Intervent Radiol (2006) 1.36
Percutaneous vertebroplasty immediately relieves pain of osteoporotic vertebral compression fractures and prevents prolonged immobilization of patients. Eur Radiol (2004) 1.36
Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study. J Bone Miner Res (2004) 1.34
Epidemiology of vertebral fractures: implications for vertebral augmentation. Acad Radiol (2006) 1.22
The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. J Vasc Interv Radiol (2006) 1.17
Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR Am J Neuroradiol (2006) 1.17
Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients. Eur Spine J (2006) 1.14
New symptomatic vertebral compression fractures within a year following vertebroplasty in osteoporotic women. AJNR Am J Neuroradiol (2005) 1.04
Treatment of chronic symptomatic vertebral compression fractures with percutaneous vertebroplasty. AJR Am J Roentgenol (2004) 1.03
Radiological follow-up of new compression fractures following percutaneous vertebroplasty. Cardiovasc Intervent Radiol (2006) 0.88
Randomized vertebroplasty trials: Current status and challenges. Acad Radiol (2006) 0.80
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol (2000) 9.76
A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology (2006) 5.29
Risk of adverse birth outcomes in populations living near landfill sites. BMJ (2001) 4.96
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med (2000) 4.18
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA (2001) 3.95
Definition of an efficient synthetic poly(A) site. Genes Dev (1989) 3.68
Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med (2000) 3.60
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis (2005) 3.53
A methodology for evaluation of boundary detection algorithms on medical images. IEEE Trans Med Imaging (1997) 3.47
Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1978) 3.23
Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med (1990) 3.02
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J (2006) 2.94
Thiamin biosynthesis in prokaryotes. Arch Microbiol (1999) 2.91
Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell (1996) 2.88
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med (2000) 2.83
Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy. Nat Struct Biol (1999) 2.75
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. Genome Res (2001) 2.66
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol (2001) 2.57
Cold shock induces a major ribosomal-associated protein that unwinds double-stranded RNA in Escherichia coli. Proc Natl Acad Sci U S A (1996) 2.55
Partial volume tissue classification of multichannel magnetic resonance images-a mixel model. IEEE Trans Med Imaging (1991) 2.50
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ (2001) 2.39
Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest (1983) 2.39
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Failure to rescue as a source of variation in hospital mortality after hepatic surgery. Br J Surg (2014) 2.34
Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region. Science (1984) 2.32
Evaluation of the medical diagnostic imaging support system based on 2 years of clinical experience. J Digit Imaging (1995) 2.29
Maternal outcomes of a randomized controlled trial of a community-based support program for families of children with chronic illnesses. Arch Pediatr Adolesc Med (2001) 2.28
Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. J Immunol (1982) 2.27
Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern Med (2001) 2.26
Structural organization of the RNA polymerase-promoter open complex. Cell (2000) 2.25
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol (2001) 2.24
A pause site for RNA polymerase II is associated with termination of transcription. EMBO J (1991) 2.23
Bacillus cereus bacteraemia. A complication of intermittent haemodialysis. Lancet (1967) 2.23
Assessment of health-related quality of life in patients with interstitial lung disease. Chest (1999) 2.21
Molecular cloning and sequence of cDNA encoding the pyrophosphate-energized vacuolar membrane proton pump of Arabidopsis thaliana. Proc Natl Acad Sci U S A (1992) 2.15
Quality control of cathode-ray tube monitors for medical imaging using a simple photometer. J Digit Imaging (1995) 2.14
Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science (1990) 2.13
End-of-life care in the intensive care unit: a research agenda. Crit Care Med (2001) 2.13
Maintenance haemodialysis. Q J Med (1969) 2.13
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA (1999) 2.12
Prevalence of diabetes and IGT in Yonchon County, South Korea. Diabetes Care (1995) 2.11
Enzymatic completion of mammalian lagging-strand DNA replication. Proc Natl Acad Sci U S A (1994) 2.11
Barriers to the use of a personal health record by an elderly population. AMIA Annu Symp Proc (2006) 2.10
Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun (1979) 2.07
The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol (1997) 2.06
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA (1990) 2.05
Infectious diarrhea secondary to Enteromonas hominis. Am J Gastroenterol (1989) 2.03
Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03
Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J Immunol (1982) 2.02
HIV risk screening in the primary care setting. Assessment of physicians skills. J Gen Intern Med (1997) 2.00
Ability of primary care physicians to recognize physical findings associated with HIV infection. JAMA (1995) 1.99
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem (2001) 1.99
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family. J Biol Chem (2000) 1.97
Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A (1998) 1.96
Parenteral administration of gentamicin in renal failure: patients undergoing intermittent haemodialysis. Br Med J (1967) 1.93
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
Can rabies be eradicated? Dev Biol (Basel) (2008) 1.91
Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem (1998) 1.90
Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res (1993) 1.90
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Blood loss using the modified two-layer Kiil dialyser. Br Med J (1967) 1.89
Nanoscale mapping of ion diffusion in a lithium-ion battery cathode. Nat Nanotechnol (2010) 1.88
Reduction of clotting in Scribner shunts by long-term anticoagulation. Br Med J (1967) 1.86
An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis (2001) 1.86
Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem (2001) 1.86
Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review. Intensive Care Med (2015) 1.85
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) (2005) 1.85
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res (2001) 1.83
Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. J Virol (1985) 1.82
Orientations of amphipathic helical peptides in membrane bilayers determined by solid-state NMR spectroscopy. J Biomol NMR (1991) 1.82
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Carbenicillin administration in patients with severe renal failure. Br Med J (1968) 1.77
Analysis of errors in medical rapid prototyping models. Int J Oral Maxillofac Surg (2002) 1.76
Concern Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill (2015) 1.75
Aggressive medical care at the end of life. Does capitated reimbursement encourage the right care for the wrong reason? JAMA (1997) 1.74
Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke (1999) 1.74
Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol (1985) (1998) 1.74
Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy (2011) 1.73
The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J Biol Chem (1999) 1.71
What is satisfying about satisfying events? Testing 10 candidate psychological needs. J Pers Soc Psychol (2001) 1.68
Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action. Proteins (1991) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Vacuolar H(+)-translocating pyrophosphatases: a new category of ion translocase. Trends Biochem Sci (1992) 1.65
Kinetic mechanism of the histone acetyltransferase GCN5 from yeast. J Biol Chem (2000) 1.62
Ten-year changes in smoking among young adults: are racial differences explained by socioeconomic factors in the CARDIA study? Am J Public Health (2001) 1.62
Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA (1990) 1.61
Life history and cost analysis for continuous rearing of Podisus maculiventris (Say) (Heteroptera: Pentatomidae) on a zoophytophagous artificial diet. J Econ Entomol (2002) 1.61
Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem (1994) 1.60
fd coat protein structure in membrane environments. J Mol Biol (1993) 1.59
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56